Prostatype Genomics presents Quarterly Report
Prostatype Genomics AB has today published its quarterly report for the second quarter comprising the period from 1 April 2022 to 30 June 2022. The report is available on the company website .Quarter 2 (1 April – 30 June 2022) summarized · Net sales amounted to 8 TSEK. · Net revenue amounted to 8 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -6 886 TSEK. · Cash flow from current operations in the quarter amounted -5 515 TSEK. · Total cash flow for the period amounted to -5 615